Medscape: Cannabis drug promising for seizures linked to tuberous sclerosis

UC epilepsy expert weighs in on use of cannabis and CBD oil for seizures

An oral formulation of highly purified cannabidiol, or CBD, reduces seizures associated with tuberous sclerosis complex by more than one third, results of a phase 3 multisite randomized trial show.

A rare genetic disorder, TSC is characterized by benign tumors that develop in many parts of the body, including the brain, where they can trigger seizures. Seizures in young children, which manifest as repetitive spasm of the head and legs, are often the presenting symptom of the disease.

Dr. Michael Privitera, professor at UC, UC Health physician and director of the Epilepsy Center at the University of Cincinnati Gardner Neuroscience Institute, said the study "is important because it provides evidence from a rigorous randomized controlled trial that broadens the uses of cannabidiol in epilepsy."

Read more.

Related Stories

1

CCM welcomes new violin faculty member Kenneth Renshaw

May 12, 2025

UC College-Conservatory of Music Dean Pete Jutras has announced the appointment of Kenneth Renshaw as CCM's new Assistant Professor of Violin. His faculty appointment officially begins on Aug. 15, 2025. Born and raised in San Francisco, Renshaw came to international attention in 2012 after winning First Prize at the Yehudi Menuhin International Violin Competition in Beijing. He was also a prize winner in the Queen Elisabeth International Violin Competition of Belgium, and First Prize recipient of the inaugural Manhattan International Concert Artists Competition.

Debug Query for this